Piramal expands manufacturing capacity by $20 Mn

19 January 2015 | News | By BioSpectrum Bureau

Piramal expands manufacturing capacity worth $20 Mn

Mr Vivek Sharma, CEO, Piramal Pharma Solutions

Mr Vivek Sharma, CEO, Piramal Pharma Solutions

In addition to investing $40M in new equipment and technologies, it is also augmenting related infrastructure.

Piramal Enterprises' Pharma Solution division, a global leader in contract development and manufacturing (CDMO), was a big winner in the recent CMO Leadership Awards, securing four awards in three key categories: quality, reliability, & regulatory.

Mr Vivek Sharma, CEO, Piramal Pharma Solutions, said, "We are delighted to receive this prestigious award and to be recognized in multiple areas and categories. The award serves as a validation of our efforts to keep the customer as the focal point, while emphasizing on project ownership, time delivery and commitment towards quality. This recognition from our clients will further motivate our team as we drive towards becoming the 'partner of choice'. Receiving these awards also showcases our company values of entrepreneurship, expertise and trusteeship."

Respondents from big pharma, mid-sized and specialty pharma, and emerging pharma, voted Piramal to be amongst the top 10 percent in these categories.

The CMO Leadership Awards by Lifescience Leader magazine is based on industry leading research conducted by Nice Insight.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account